Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 30, 2017 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Retains Facet Life Sciences to Guide Pancreatic Cancer Therapy Development Lifecycle with FDA

LAGUNA HILLS, Calif., Jan. 30, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
January 18, 2017 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech to Hold Shareholder Call

LAGUNA HILLS, Calif., Jan. 18, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
January 10, 2017 09:10 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Discusses Upcoming Clinical Trial with Principal Investigator Dr. Manuel Hidalgo

LAGUNA HILLS, Calif., Jan. 10, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
January 04, 2017 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Announces Pre-IND Meeting Date with FDA

LAGUNA HILLS, Calif., Jan. 04, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
December 27, 2016 09:30 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers

LAGUNA HILLS, Calif., Dec. 27, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
December 15, 2016 09:46 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Submits Pre-IND Meeting Package to FDA

LAGUNA HILLS, Calif., Dec. 15, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
December 07, 2016 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Discusses Upcoming Clinical Trial in Pancreatic Cancer with First Principal Investigator

LAGUNA HILLS, Calif., Dec. 07, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
November 29, 2016 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Granted FDA Pre-IND Meeting for Pancreatic Cancer Therapy

LAGUNA HILLS, Calif., Nov. 29, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
November 14, 2016 09:00 ET | Source: PharmaCyte Biotech, Inc.

University of Northern Colorado Presenting PharmaCyte Biotech’s Cannabis Research at the 2017 American Chemical Society National Meeting

LAGUNA HILLS, Calif., Nov. 14, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
November 01, 2016 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Requests Pre-IND Meeting with FDA for its Pancreatic Cancer Clinical Trial

LAGUNA HILLS, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...